Habib J. Dable's most recent trade in Blueprint Medicines Corp was a trade of 3,902 Common Stock done at an average price of $128.1 . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 128.12 per share. | 18 Jun 2025 | 3,902 | 12,644 (0%) | 0% | 128.1 | 499,924 | Common Stock |
| PepGen Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Day One Biopharmaceuticals... | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 22,500 | 22,500 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharmaceuticals... | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 15,000 | 15,000 | - | - | Restricted Stock Unit (RSU) | |
| PepGen Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 4,570 | 4,570 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 2,242 | 8,742 (0%) | 0% | 0 | Common Stock | |
| Jade Biosciences Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Day One Biopharmaceuticals... | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| Jade Biosciences Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 1,531 | 1,531 | - | - | Stock Option (Right to Buy) | |
| Day One Biopharmaceuticals... | J. Dable Habib | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 66,660 | 66,660 | - | - | Stock Option (right to buy Common Stock) | |
| Jade Biosciences Inc | J. Habib Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 2,964 | 2,964 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Habib J. Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| PepGen Inc | Habib J. Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Habib J. Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 5,300 | 5,300 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Habib J. Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 2,600 | 6,500 (0%) | 0% | 0 | Common Stock | |
| PepGen Inc | Habib J. Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 22,686 | 22,686 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Habib J. Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 7,950 | 7,950 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Habib J. Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 3,900 | 3,900 (0%) | 0% | 0 | Common Stock |